MSB 3.42% $1.21 mesoblast limited

Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-306

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    yeah, you could apply your brilliant logic to a decade ago at $10 too....

    short term blip since then too I guess, Novartis stole the Osiris dump, MSB should be thankful I guess as they start again with a proper manufacturing system in pre-clinical....

    Surely Novartis won't accept 7 years of "talk" in an annual report.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.